Strategic deworming in horses shifts focus to testing, not rotation: full analysis

Strategic deworming in horses has moved well beyond the old model of rotating products on a fixed schedule. Current guidance emphasizes surveillance-based parasite control: use fecal egg counts to classify shedding status, perform fecal egg count reduction tests to verify drug efficacy, and reserve additional treatments for horses that are actually contributing most to pasture contamination. That approach aligns with the American Association of Equine Practitioners’ updated Internal Parasite Control Guidelines, revised in May 2024. (aaep.org)

The background to this shift is long-running concern about anthelmintic resistance in equine parasites. The Horse article’s advice to perform a fecal egg count before deworming reflects a broader industry move away from routine interval dosing and toward targeted control. AAEP’s updated guidance explicitly says to discontinue year-round fixed-interval deworming, such as every two months, and to stop blindly rotating anthelmintic classes. Merck Veterinary Manual echoes that fecal egg counts are necessary tools for monitoring resident parasite populations and that fecal egg count reduction testing is imperative for evaluating treatment efficacy. (aaep.org)

The details matter. For mature horses ages 5 to 15 years, AAEP recommends one or two baseline macrocyclic lactone treatments per year to address large strongyles, bots, and related parasites, with praziquantel included at least once yearly for horses on green pasture to address tapeworms. Additional treatment should be directed at high strongyle shedders, defined in the guideline as horses with more than 500 eggs per gram, and timed to local transmission seasons rather than the calendar alone. The guidance also stresses that fecal egg counts are useful for surveillance, but not for diagnosing clinical parasitic disease, because egg counts do not correlate well with total worm burden or pathogenic larval stages. (aaep.org)

AAEP also gives practices a more operational framework for resistance testing. The guideline advises annual fecal egg count reduction testing in each herd or barn and notes that, while larger group testing is preferred, a single-horse treatment check can still be informative in some situations, such as quarantine for a newly arrived horse. In that case, a dewormer should reduce ascarid and strongyle egg counts by more than 95% at 14 days after treatment, though the organization cautions that low pretreatment egg counts make results less reliable. (aaep.org)

There are also important age-specific differences. For foals, weanlings, yearlings, and other young horses, AAEP says targeted selective therapy based on fecal egg counts is not recommended, even though fecal monitoring remains important. In this group, ascarids are a primary target, and the guideline says macrocyclic lactone resistance should be assumed until documented otherwise. Merck adds that ascarid infection is common in foals and can lead to small intestinal impaction, sometimes requiring surgery. (aaep.org)

Expert and industry perspective is relatively consistent: the goal is no longer eradication, but sustainable control. The AAEP task force’s “six changes worth making” include routinely checking efficacy with fecal egg count reduction testing, reducing treatment frequency, tailoring strongyle control to active transmission seasons, and abandoning rotational deworming. Merck similarly emphasizes that climate, geography, herd management, and age all shape parasite risk, which is why one-size-fits-all schedules have become harder to justify. (aaep.org)

Why it matters: For veterinary professionals, strategic deworming turns parasite control into a year-round preventive medicine service rather than a product-dispensing routine. It creates a stronger role for the veterinarian in interpreting fecal egg counts, designing age-appropriate protocols, deciding when baseline treatment is still warranted, and documenting efficacy on each farm. It also gives practices a clearer way to talk with pet parents and horse managers about why fewer treatments can actually be better medicine when they preserve drug effectiveness and reduce unnecessary selection pressure for resistance. (aaep.org)

What to watch: The next phase is likely to be broader adoption of farm-specific surveillance protocols, more routine annual resistance checks, and closer attention to emerging reports of reduced efficacy, including recent AAEP-noted concerns about tapeworm treatment failure in Central Kentucky. (aaep.org)